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Inhibitor of growth 2 (ING2) gene encodes a candidate tumor suppressor and is frequently
reduced in many tumors. However, the mechanisms underlying the regulation of ING2, in partic-
ular its protein stability, are still unclear. Here we show that the homologous to E6AP carboxyl
terminus (HECT)-type ubiquitin ligase Smad ubiquitination regulatory factor 1 (Smurf1) interacts
with and targets ING2 for poly-ubiquitination and proteasomal degradation. Intriguingly, the
ING2 binding domain in Smurf1 was mapped to the catalytic HECT domain. Furthermore, the
C-terminal PHD domain of ING2 was required for Smurf1-mediated degradation. This study pro-
vided the ﬁrst evidence that the stability of ING2 could be regulated by ubiquitin-mediated deg-
radation.
Structured summary:
MINT-7894271: ING2 (uniprotkb:Q9H160) binds (MI:0407) to Smurf1 (uniprotkb:Q9HCE7) by pull-
down (MI:0096)
MINT-7894319, MINT-7894339: ING2 (uniprotkb:Q9H160) physically interacts (MI:0915) with Smurf1
(uniprotkb:Q9HCE7) by anti tag co-immunoprecipitation (MI:0007)
MINT-7894301: Smurf1 (uniprotkb:Q9HCE7) physically interacts (MI:0915) with ING2 (uni-
protkb:Q9H160) by anti bait co-immunoprecipitation (MI:0006)
MINT-7894358: ING1b (uniprotkb:Q9UK53-2) physically interacts (MI:0915) with Smurf1 (uni-
protkb:Q9HCE7) by anti tag co-immunoprecipitation (MI:0007)
MINT-7894249: ING2 (uniprotkb:Q9H160) physically interacts (MI:0915) with ubiquitin (uni-
protkb:P62988) by anti tag co-immunoprecipitation (MI:0007)
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The human inhibitor of growth (ING) family members, consist-
ing of ING1 to ING5, play a signiﬁcant role in a broad variety of cel-
lular events, such as growth regulation, senescence, apoptosis, DNA
damage repair, transcription regulation and chromatin remodeling
[1]. All ING proteins contain a highly conserved C-terminal plant
homeodomain (PHD) ﬁnger motif which has been shown to recog-
nize histone H3 trimethylated at lysine 4 (H3K4me3). The ING pro-
teins also possess nuclear localization sequences (NLS), which are
critical for the ING proteins to be localized in the nucleus [1,2].lsevier B.V. All rights reserved.
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associations with speciﬁc molecular partners which could be di-
vide into three groups: components of HAT or HDAC complexes,
nuclear transcriptional factors (e.g., p53 and NFjB), and the phos-
phoinositides (PtdInsPs) among the signaling lipids. The tumor
suppressor genes are divided into two classes: the caretakers (or
type I) and the gatekeepers (or type II). The former are usually
DNA repair genes and protect the genome from mutations,
whereas the latter prevent cancer through direct control of cell
growth. Thus, restoration of missing gatekeeper functions to cancer
cells leads to suppression of the neoplastic growth; whereas resto-
ration of caretaker functions will not affect their growth [3]. As
type II tumor suppressors, ING genes have been reported to be fre-
quently dysregulated in human tumors, and various mechanisms,
including mutations within ING genes, downregulation of gene
expression, and protein mislocalization, have been proposed to ex-
plain how ING function is altered in the tumors [1,4,5].
ING2 was identiﬁed as the second member of ING family. Be-
sides the conserved C-terminal PHD ﬁnger domain, ING2 also con-
tains a central NLS sequence and a unique leucine zipper-like (LZL)
domain at the N-terminus. The LZL domain is thought to mediate
hydrophobic protein–protein interaction [6]. ING2 has been re-
ported to regulate cell growth, apoptosis, DNA repair, chromatin
remodeling and gene expression through association with various
proteins including mSin3A–HDAC complex, p300, the SWI–SNF–
BRG1 complex, RBP1, and H3K4me3 [7–10]. Moreover, ING2 could
also interact with PtdInsPs including PtdIns(3)P and PtdIns(5)P via
its PHD domain and functions as a speciﬁc nuclear PtdInsP recep-
tor. By this means, ING2 is able to activate p53 and cooperates with
p53 to induce cellular growth arrest and apoptosis [11].
Previous studies on ING2 status in cancer have indicated that
ING2 participation in tumorigenesis is likely to be related to its
expression level rather than its mutational status. Using the tissue
microarray technology and immunohistochemistry analysis, the
nuclear expression of ING2 is reduced in human melanomas com-
pared to dysplastic nevi [12]. Similar results were observed in
investigating the status of ING2 in a series of 120 non-small cell
lung cancer (NSCLC) samples by using immunohistochemistry.
ING2 protein expression is downregulated in more than 50% of
NSCLC, with a higher frequency in adenocarcinoma as compared
to squamous cell carcinoma. However, neither heterozygosity nor
mutation in the ING2 gene could be detected [13]. Furthermore,
the protein level of ING2 was also found to be decreased in hepa-
tocellular carcinoma [14]. However, the mechanism responsible for
ING2 regulation, in particular its protein stability, is poorly
understood.
Here we demonstrate a critical role of Smad ubiquitination reg-
ulatory factor 1 (Smurf1) in regulating ING2 protein stability.
Smurf1 belongs to the homologous to E6AP carboxyl terminus
(HECT) domain-type ubiquitin-protein ligase (E3) and plays a piv-
otal role in control of cell polarity, maintenance of bone homeosta-
sis and regulation of tumorigenesis through targeting BMP-Smad,
Wnt and RhoA signalling pathways [15–18]. In this study, we
found that Smurf1 interacts with ING2 both in vivo and in vitro,
targets ING2 for poly-ubiquitination and proteasomal degradation.
As far as we know this is the ﬁrst evidence to establish the rele-
vance between the ING2 protein and E3 ligase.2. Materials and methods
2.1. Plasmid constructs
Full-length, truncated, and point mutations of Smurf1 and ING2
were constructed by inserting PCR ampliﬁed fragments into the
related vectors. Detailed construct information is available uponrequest. pCMV/p53 was provided by Dr. Yue Xiong. 6Myc-Smurf1
wild-type, 6Myc-Smurf1-C699A and Flag-Smurf1 were provided
by Dr. Kohei Miyazono. Myc-ING1b, Myc-ING2, Flag-ING3, HA-
ING4 and Flag-ING5 were gifts from Dr. Karl Riabowol and Dr. Cutis
C. Harris.
2.2. Reagents and antibodies
The protein synthesis inhibitor cycloheximide (CHX), anti-Flag
and anti-ING2 antibodies were purchased from Sigma. Anti-HA
antibody from Roche, anti-Myc antibody from MBL, and anti-
Smurf1 antibody was bought from Abcam. Anti-GST and anti-His
were from Tiangen. Anti-GAPDH (6C5) and secondary antibodies
were purchased from Santa Cruz Biotechnology.
2.3. Cell culture and transfections
Human embryonic kidney HEK293T cells, human breast cancer
MCF7 cells were cultured in DMEM medium (Hyclone) containing
10% fetal bovine serum (FBS; Hyclone). Human lung adenocarci-
noma H1299 cells were maintained in RPMI 1640 medium (Hy-
clone) with 10% FBS. Mammalian cells were transiently
transfected with Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions.
2.4. Immunoprecipitation and immunoblotting
Cell lysates were prepared in HEPES lysis buffer (20 mM HEPES,
pH 7.2, 50 mM NaCl, 0.5% Triton X-100, 1 mM NaF, and 1 mM DTT)
supplemented with protease inhibitors. Immunoprecipitations
were performed using primary antibody and protein A/G-agarose
beads at 4 C. Lysates and immunoprecipitates were examined
using the indicated primary antibodies and then secondary anti-
body, followed by detection with SuperSignal chemiluminescence
kit (Pierce).
2.5. In vivo and In vitro ubiquitination assays
For in vivo ubiquitination assay, cells were treated with MG132
(20 lM) for 8 h before harvested. The cell lysis were prepared in
modiﬁed RIPA lysis buffer (10 mM Tris–HCl [pH 7.5], 150 mMNaCl,
5 mM EDTA, 1% (v/v) NP-40, 1% sodium deoxycholate, 0.025% SDS,
protease inhibitors), and immunoprecipitated with the indicated
antibody, and detected by immunoblotting.
For in vitro ubiquitination assay, His-Smurf1, GST-ING2 were
expressed in Escherichia coli and puriﬁed with Ni-nitrilotriace-
tate-agarose beads (Qiagen) and glutathione-Sepharose 4B beads
(Amersham) respectively, as we described [19]. The assays were
carried out in 30 ll ubiquitination assay buffer (50 mM Tris pH
8.0, 50 mM NaCl, 1 mM DTT, 5 mM MgCl2, and 3 mM ATP), with
0.7 lg of E1, 1 lg of UbcH5c (E2), 15 lg HA-ubiquitin (all from Bos-
ton Biochem, MA), 0.7 lg of His-Smurf1 (wild-type or C699A mu-
tant) and 1.5 lg GST-ING2. Samples were incubated at 30 C for
2 h and terminated with sample buffer.
2.6. Reporter gene assay and apoptosis assay
The luciferase reporter plasmid pG13-Luc (pG13L, containing 13
tandem repeats of p53-binding sites) was a gift from Bert Vogel-
stein. The luciferase reporter assays were performed as we de-
scribed previously [20]. Luciferase activity was measured with
the Dual Luciferase Assay System (Promega) in accordance with
the manufacturer’s protocol. Apoptosis assay was performed with
Annexin V staining method followed by ﬂow cytometry analysis
as described [20].
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The Smurf1-speciﬁc siRNA (50-GCAUCGAAGUGUCCAGAGAAG-
30), ING2-speciﬁc siRNA (50-UCGGGCAAGACAAAUGGAGUU) and
non-target control siRNA (50-UUCUCCGAACGUGUCACGU-30) were
synthesized by Shanghai GenePharm. The siRNAs were transfected
with Lipofectamine 2000.
2.8. Real-time RT-PCR
Real-time quantitative PCR was performed as described previ-
ously [21]. Reactions were done in triplicate, and relative amounts
of cDNA were normalized to GAPDH. Primers used were as follows:
Smurf1 F, 50-CTACCAGCGTTTGGATCTAT-30 and Smurf1 R, 50-TGTC-
TCGGGTCTGTAAACT-30; ING2 F, 50-CACAAATGCTCGAATTGGTGG-30
and ING2 R, 50-TGCTTTATCTGAGGCTCGTTCA-30; Puma F, 50-GAC-
CTCAACGCACAGTA-30 and Puma R, 50-CTAATTGGGCTCCATCT-30;
p21 F, 50-CACCGAGACACCACTGGAGG-30 and p21 R, 50-GAGA-
AGATCAGCCGGCGTTT-30; GAPDH F, 50-GGGAAGGTGAAGGTCG-
GAGT-30 and GAPDH R, 50-TTGAGGTCAATGAAGGGGTCA-30. F and
R represent forward and reverse primer, respectively.
3. Results and discussion
3.1. Smurf1 negatively regulates the protein level of ING2 in a
proteasome-dependent manner
The ubiquitin-proteasome pathway is one of the most impor-
tant pathways that regulate protein degradation. To explore the
mechanism responsible for ING2 stability regulation, we ﬁrstFig. 1. Smurf1 negatively regulates the protein level of ING2. (A) MG132 treatment up
(20 lM) for 8 h before harvest. Endogenous ING2 level was analyzed by immunoblot
endogenous ING2 protein level. MCF7 cells were transfected with Flag-tagged wild-type
or without the proteasome inhibitor MG132 (20 lM) for 8 h before harvest. The endogeno
in a dose-dependent manner. MCF7 cells were transfected with the increasing amount o
effect on the mRNA level of ING2. The ING2 mRNA prepared from the transfected MCF7
deviation (S.D., n = 3). (E and F) Smurf1 depletion increased the endogenous ING2 protein
with non-targeted control (NC) or Smurf1–speciﬁc (S1) siRNA, and the endogenous ING2
mean ± S.D. (n = 3).detected whether ING2 protein turnover is regulated through the
proteasome pathway. The level of endogenous ING2 protein
increased signiﬁcantly after treatment with MG132, a potent pro-
teasome inhibitor (Fig. 1A), suggesting that ING2 protein could
be degraded in a proteasome system.
The process of ubiquitination involves the sequential transfer of
ubiquitin between a ubiquitin-activating enzyme (E1), a ubiquitin-
conjugating enzyme (E2) and a E3. E3s are ﬁnal effectors of the
enzyme cascade controlling ubiquitination and determine the
speciﬁcity of substrate recognition. We next screened possible E3
regulator of ING2 from its interacting proteins. A high-throughput
screening of TGF-b signalling network system identiﬁed ING1L (i.e.
ING2) could interact strongly with both the wild-type (WT) Smurf1
ligase and the C699A ligase-inactive mutant [22]. Notably, this
interaction is speciﬁc since ING2 neither interacts with Smurf2,
the close member of Smurf1 among the neural precursor cells-ex-
pressed developmentally-downregulated gene 4 (Nedd4) family,
nor with Smads and the TGF-b/BMP receptors among the TGF-b/
BMP network. On the other hand, Smurf1 speciﬁcally interacts
with ING2 but not with ING3 or ING4 [22]. Smurf1 has been dem-
onstrated to target Smad1, Smad5, RhoA, MEKK2, Prickle1, PEM-2
and TRAFs for ubiquitination and degradation [15–18,23–25]. Then
we hypothesized that Smurf1 might function as an E3 ligase in the
ING2 degradation.
To test our hypothesis, ING2 protein level was analysed in the
presence of ectopic Smurf1 or its CA mutant. Smurf1-WT signiﬁ-
cantly reduced the endogenous ING2 protein levels; in contrast,
Smurf1-CA mutant slightly increased it which might be caused
by a dominant negative effect (Fig. 1B, lanes 1–3). MG132 treat-
ment blocked the downregulation of ING2 by Smurf1 (lane 4),regulates ING2 protein level. MCF7 breast cancer cells were treated with MG132
ting (IB). GAPDH was analyzed as an internal control. (B) Smurf1 decreases the
(WT) Smurf1 or its ligase-inactive mutant (C699A). The cells were then treated with
us ING2 level was analyzed. (C) Smurf1 decreases the exogenous ING2 protein level
f Smurf1 together with ING2, and the ING2 level was detected. (D) Smurf1 has no
cells was analyzed by real-time PCR assay. Data are presented as mean ± standard
level but had no effect on ING2 mRNA level. MCF7 or H1299 cells were transfected
and Smurf1 level were analyzed by IB (E) or real-time PCR (F). Data are presented as
Fig. 2. Smurf1 promotes the ubiquitination and degradation of ING2. (A) Smurf1 shortens the half life of endogenous ING2 protein. MCF7 cells were transfected with control
plasmid or Flag-Smurf1, and cells were treated with the protein synthesis inhibitor cycloheximide (CHX, 10 lg/ml) for the indicated times before harvest. ING2 protein
expression was analyzed. (B) Depletion of Smurf1 prolonged the half life of endogenous ING2 protein. MCF7 cells were transfected with control siRNA or Smurf1 siRNA,
treated with CHX and ING2 protein expression was analyzed. (C) Smurf1 catalyzes the ubiquitination of ING2 in vitro. Puriﬁed HA-ubiquitin, E1, E2 (UbcH5c), bacterial-
expressed and puriﬁed His-Smurf1 WT or CA, GST-ING2 or GST were mixed for in vitro ubiquitination assays and immunoblotted with anti-HA. (D) Smurf1 enhances the
ubiquitination of ING2 in vivo. MCF7 cells were transfected with HA-Ub, Myc-ING2, control vector or Flag-Smurf1, and treated with MG132 as indicated. Ubiquitinated ING2
was immunoprecipitated (IP) by anti-Myc antibody and analyzed by IB.
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degradation. Smurf1 also negatively regulated the levels of exoge-
nous ING2 protein in a dose-dependent manner (Fig. 1C). This reg-
ulation was not due to the change of ING2 mRNA abundance
(Fig. 1D). These results suggested that Smurf1 promoted ING2 deg-
radation dependent of its E3 ligase activity. To conﬁrm the role of
Smuf1 in regulating the ING2 protein stability in vivo, we de-
creased Smurf1 expression using small interfering RNA (siRNA).
Downregulation of endogenous Smurf1 signiﬁcantly increased
ING2 levels in both MCF7 and H1299 cells (Fig. 1E). Again, Smurf1
depletion had no signiﬁcant effect on the mRNA level of ING2
(Fig. 1F).
3.2. Smurf1 promotes the poly-ubiquitination of ING2
To examine whether the effect of Smurf1 on the ING2 protein
levels is through stabilization of the protein, we measured the half
life of ING2 protein. When cells were treated with cycloheximide
(CHX), the protein synthesis inhibitor, the turnover of endogenous
ING2 was dramatically accelerated by co-expression of Smurf1
(Fig. 2A), while depletion of Smurf1 prolonged the half life of
ING2 (Fig. 2B). To determine whether Smurf1 could directly cata-
lyze the ubiquitination of ING2, we reconstituted an in vitro ubiq-
uitination system using puriﬁed E1 and E2 (UbcH5c), bacteria-
expressed His-Smurf1 and GST-ING2 or GST alone as a control. In
this system, Smurf1-WT but not Smurf1-CA efﬁciently catalyzed
the poly-ubiquitination of ING2 (Fig. 2C). In vivo ubiquitination as-
say showed that overexpression of Smurf1 signiﬁcantly increased
the poly-ubiquitination of ING2 in the presence of MG132
(Fig. 2D). These results suggested that Smurf1 functions as a candi-
date E3 ligase of ING2 for ubiquitination and degradation.
3.3. Smurf1 associates with ING2 both in vitro and in vivo
E3 ligase can interact with its substrates and facilitate the trans-
fer of ubiquitin to one or more lysine residues in the substrates. To
conﬁrm the interaction between Smurf1 and ING2, in vitro GST
pull-down assays with recombination His-Smurf1 and GST-ING2were ﬁrst performed, and the speciﬁc interaction of Smurf1 with
GST-ING2, but not with GST alone was observed (Fig. 3A). To assess
whether ING2 interacts with Smurf1 in vivo, a co-immunoprecipi-
tation (Co-IP) assay was performed and the result revealed an asso-
ciation between endogenous Smurf1 and ING2 in the presence of
MG132 (Fig. 3B). Thus, Smurf1 interacts with ING2 both in vitro
and in vivo.
It has been well-deﬁned that the WW domains of HECT E3s rec-
ognize the PPxY or PxxY (PY) motif of substrate [26]. However, no
PY motif exists within ING2 protein. To clearly characterize the
association between Smurf1 and ING2, we generated several
Smurf1 deletion mutants to map the ING2-interacting region. Co-
IP assays indicated that the HECT domain but not the C2 or WW
domains of Smurf1-mediated the interaction with ING2 (Fig. 3C).
Importantly, the HECT domain was both required and sufﬁcient
for Smurf1 to promote the degradation of ING2 (Fig. 3D) and to cat-
alyze the poly-ubiquitination of ING2 in vitro (Fig. 3E) and in MCF7
cells (Fig. 3F).
We next mapped the binding region of ING2 with Smurf1. As
shown in Fig. 3G, deletion of PHD domain together with the ex-
treme C-terminus had no signiﬁcant effect on the interaction be-
tween ING2 and Smurf1 (lane 5). Similarly, deletion of LZL region
also had no signiﬁcant effect on the interaction (lane 3). The central
region (DLZLDPHD, aa 64–220) was sufﬁcient for Smurf1 binding
although the afﬁnity seems to decrease slightly (lane 4). We also
tested the truncate with either the LZL or the PHD alone but failed
due to the unsuccessful expression of these truncate constructs
with undetermined reasons. These data suggested that the LZL or
PHD domain was not required for ING2 binding to Smurf1
(although we cannot rule out this possibility) and the central re-
gion was sufﬁcient for this binding.
3.4. The PHD domain of ING2 is critical for Smurf1-mediated
degradation
To further explore the regulation mechanism of ING2 by
Smurf1, we detected the effect of Smurf1 on the ING2 mutants to
narrow down the region where ING2 is targeted by Smurf1.
Fig. 3. Smurf1 interacts with ING2 in vitro and in vivo. (A) Direct interaction between Smurf1 and ING2 is revealed by GST pull-down assays. Input and pull-down sampleswere
both subjected to immunoblotting with anti-GST and anti-His antibodies. Input represents 10% of that used for pull-down. (B) Co-immunoprecipitation of endogenous Smurf1
and ING2. To avoid the degradation of ING2, MG132 were added in MCF7 cells for 8 h before harvested. Cell lysates were immunoprecipitated with anti-Smurf1 antibody or a
normal control IgG and all samples were analyzed by IB. IgG HC, heavy chain of IgG. (C) Smurf1 HECT domain mediates the interaction with ING2 protein. ING2 and Smurf1
deletionmutantswere transfected intoHEK293T cells. Cell lysateswere immunoprecipitatedwith anti-Flag antibody. Both the lysate (bottom) and immunoprecipitates (upper)
were analyzed by IB. (D) Smurf1 HECT domain determines the regulation of ING2. Flag-ING2 and Smurf1 WT or mutants were cotransfected into MCF7 cells. Cell lysates were
analyzed by IB. (E) Smurf1 HECT domain catalyzed the poly-ubiquitination of ING2 in vitro. Puriﬁed HA-ubiquitin, E1, E2 (UbcH5c), bacterial-expressed and puriﬁed Smurf1WT
ormutant, GST-ING2weremixed for in vitro ING2ubiquitination assays and immunoblottedwith anti-HA. (F) Smurf1HECTdomain promoted the ubiquitination of ING2 in vivo.
HA-Ub, Flag-ING2 and Smurf1 constructswere cotransfected intoMCF7 cells, and treatedwithMG132. Ubiquitinated ING2was immunoprecipitatedwith anti-HA antibody and
analyzed by IB. (G) The central region (aa 64–220) of ING2 binds to Smurf1. Smurf1 and the indicated deletionmutants of ING2were transfected into HEK293T cells. Cell lysates
were immunoprecipitatedwith anti-Myc antibody. Both the lysate (bottom) and immunoprecipitates (upper)were analyzed by IB. (H) The PHDdomain of ING2 is crucial for the
degradation of ING2by Smurf1. Upper:MCF7 cellswere transfectedwith Flag-Smurf1 andMyc-ING2WTormutants, and the cell lysateswere subjected to immunoblot analysis.
Lower: MCF7 cells were transfected with Myc-ING2 WT or mutants, and treated with or without MG132 (20 lM) for 8 h before harvest. Cell lysates were analyzed by IB.
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3010 J. Nie et al. / FEBS Letters 584 (2010) 3005–3012Western blot analysis indicated that the PHD region of ING2 was
crucial for Smurf1-mediated degradation (Fig. 3H). A deletion mu-
tant lack of the extreme C-terminal 15 residues (named as DC15)
was further generated in order to examine whether the PHD do-
main itself or the extreme C-terminus was critical in the degrada-
tion. Co-expression of Smurf1 signiﬁcantly decreased the level of
ING2-DC15 (Fig. 3H upper, lane 8), indicating that the extreme
C-terminus was not required for this degradation. Thus, the PHD
domain itself should contain the degradation signal recognized
by Smurf1. We also observed that the protein levels of ING2 DLZL,
DC15 and WT were signiﬁcantly increased in the presence of pro-Fig. 4. Smurf1 regulates the stability of ING2, ING1b and inhibits ING2-mediated p53 t
indicated INGs plasmids were transfected into MCF7 cells together with or without Smu
ING1b, but not with ING3, ING4 or ING5. Smurf1-CA and INGs constructs were transfecte
Flag (or Myc) antibody. Both the lysate (bottom) and immunoprecipitates (upper) were
asterisks indicate ING proteins (left). (C) Protein sequence alignment of ING2 with the ot
terminus sequence of ING2 as 100%, and blast the corresponding regions of other ING p
Nedd4 family E3 ligases. Flag-tagged nine members of Nedd4 family of E3 ligases were e
E3s were analyzed by immunoblotting with the indicated antibodies. (E) Effects of Smu
were transfected with the indicated constructs. p53 activity was measured by reporter ge
are mean ± S.D. (n = 3). (F) The effect of Smurf1 on the expression of p53 targeted genes.
quantitative real-time PCR analysis. Data are mean ± S.D. (n = 3). (G) The effect of Smurf1
with etoposide (100 lM) for 20 h. Apoptosis was determined by staining with Annexinteasome inhibitor MG132, while the level of DPHD was unchanged
(Fig. 3H lower panels), further indicating that the PHD domain was
important for proteasome-mediated ING2 degradation.
3.5. Smurf1 speciﬁcally regulates ING2 and ING1b among ING family
members and inhibits ING2-mediated activation of p53
ING family consists of ﬁve members. We next examined
whether Smurf1 played a universal role in targeting ING family
proteins for degradation. There are three splicing isoforms of
ING1 gene, p33ING1b, p47ING1a, p27ING1d, and another variantransactivation. (A) The possible regulation of Smurf1 on ING family members. The
rf1. The protein levels of INGs were analyzed. (B) Smurf1 interacts with ING2 and
d into HEK293T cells as indicated. Cell lysates were immunoprecipitated with anti-
analyzed by IB. HC and LC represent heavy and light chain of IgG, respectively. The
her human ING proteins. Take the LZL, central region, and PHD plus the extreme C-
roteins with ING2, respectively. (D) ING2 speciﬁcally interacts with Smurf1 among
ach coexpressed with ING2 in MCF7 cells. The expression levels of ING2 and Nedd4
rf1 on p53 activity. p53-wild-type MCF7 (left) or p53-deﬁcient H1299 cells (right)
ne assay. Representative results of three independent experiments are shown. Data
Total RNA from ING2 RNAi or/and Smurf1 RNAi-treated MCF7 cells was subjected to
on cell apoptosis. ING2 RNAi or/and Smurf1 RNAi-treated MCF7 cells were incubated
V followed by ﬂow cytometry analysis. Data are mean ± S.D. (n = 3).
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characterized isoform [27]. ING2 exhibits 70% sequence homology
to p33ING1b [28]. Phylogeny studies have shown that ING1 and
ING2 on the one hand, whereas ING4 and ING5 on the other hand,
have an overall high homology and, therefore, could have closely
related functions [29]. Indeed, Smurf1 was able to promote the
degradation of ING1 as well. By contrast, Smurf1 had no signiﬁcant
effect on the protein levels of ING3, ING4 and ING5 (Fig. 4A). Co-
immunoprecipitation assays showed that Smurf1 interacted with
ING2 and ING1b, but not with ING3, ING4 or ING5 (Fig. 4B), consis-
tent with previous study [22]. Sequence alignment clearly indi-
cates that the homology of the central region (aa 64–220)
between ING2 and ING1b is 50%, much higher than that of ING3,
ING4 and ING5 (5%, 25%, 24%, respectively), while the PHD region
is conserved in all ING proteins (Fig. 4C). Given that the central re-
gion of ING2 is responsible for Smurf1 binding (Fig. 3G), the differ-
ential homology of this region among ING family explains why
ING2 and ING1b interact with Smurf1, whereas ING3, ING4 and
ING5 do not. In addition, among the Nedd4 family is Smurf1 which
speciﬁcally downregulated the stability of ING2 protein (Fig. 4D).
Previous studies revealed that ING2 could interact with p53 and
enhance its transcriptional activity. We next examined whether
Smurf1-dependent degradation of ING2 interfered p53 activity.
As expected, the transcriptional activity of endogenous p53 in
MCF7 cells was increased when ING2 was overexpressed. This ele-
vation was reduced by Smurf1-WT but not the Smurf1-CA mutant
(Fig. 4E, left), indicating that Smurf1 affects ING2 function depen-
dently of its ligase activity. To conﬁrm the effect of Smurf1 on
ING2-mediated p53 transactivation, the p53-deﬁcient H1299 cells
was used. P53 activity could not be detected in these cells; when
exogenous p53 was reintroduced, the activity of p53-binding pro-
moter-driven luciferase was easily detected. ING2 enhanced the
p53 activity and Smurf1 further inhibited the ING2 function depen-
dently of the ligase activity (Fig. 4E, right).
Knockdown of Smurf1 by siRNA transfection signiﬁcantly up-
regulated the mRNA levels of p53 downstream target genes includ-
ing p21 and Puma (Fig. 4F), and enhanced the cell apoptosis in-
duced by etoposide (Fig. 4G). ING2 knockdown had the opposite
effect, consistent with previous reports [11]. Importantly, abroga-
tion of ING2 together with depletion of Smurf1 partially (but still
signiﬁcantly) inhibited Smurf1 knockdown-induced p53 target
gene upregulation and apoptosis augmentation (Fig. 4F and G),
indicating that Smurf1 functions partially through ING2 to regulate
p53 activity and apoptosis.
Taken together, we identiﬁed the HECT-type ubiquitin ligase
Smurf1 could target the tumor suppressor ING2 for ubiquitination
and proteasome-dependent degradation and further inﬂuence the
effect of ING2 on p53 activity. Depletion of Smurf1 resulted in a
signiﬁcant upregulation of ING2 protein level. In vivo and in vitro
ubiquitination assay showed that ING2 was a new substrate of
E3 ligase Smurf1. Recently, it has been demonstrated that ING3
is degraded by the ubiquitin-proteasome pathway through the
RING ﬁnger-type E3 ligase SCFSkp2 complex and lysine 96 residue
is essential for ING3 ubiquitination [30]. Moreover, p33ING1b is de-
graded in the 20S proteasome and NAD(P)H quinone oxidoreduc-
tase 1 (NQO1) inhibits the degradation of p33ING1b [31]. ING4 is
also degraded by the ubiquitin-proteasome pathway and nucleolar
accumulation of ING4 prolongs its half life although the responsi-
ble E3 ligase remains unclear [32]. These ﬁndings illustrate that
most of ING family proteins undergo ubiquitin-proteasome-medi-
ated degradation. Our study for the ﬁrst time shows that ING2 can
be targeted for ubiquitin-proteasomal degradation through the
HECT domain-type E3 ligase Smurf1, and thus provides a func-
tional crosstalk between ING family of tumor suppressors and
Nedd4 family of ubiquitin ligases.Notably, Smurf1 interacts with ING2 and targets ING2 for deg-
radation completely dependent on the HECT domain. It has been
well-characterized that the central WW domains mediate the rec-
ognition of most of the deﬁned substrates including Smad1/5,
RhoA, MEKK2, Prickle1 and TRAFs [15,17,18,23,24], although a
most recent study indicated that the N-terminal C2 domain might
also mediate the interaction with the substrate PEM-2, a guanine
nucleotide exchange factor for Cdc42 [25]. Our data indicate that
the HECT domain could also function as the substrate recognition
module and thus, contribute to deepen the understandings of the
functions of HECT domain. How the HECT domain itself coordi-
nates both the substrate binding and the ubiquitin transfer is wor-
thy of precise investigations.
Our study also gained further insight into the novel role of PHD
ﬁnger domain in the stability control of ING2. Although a subclass
of putative PHD ﬁngers were shown to have E3 ubiquitin ligase
activity, the PHD ﬁngers in ING family have not been suggested
to possess such a function. Instead, they were found to mediate
the interaction with lipid including PtdIns(5)P in vivo and also
PtdIns(3)P in vitro, and with histone H3 trimethylated at lysine
4. We revealed that the PHD ﬁnger domain was required for
Smurf1-mediated degradation. Although studies with the other
ING proteins (such as ING3 and ING4) reported that the N-terminal
region was involved in ING ubiquitination [30,32], the C-terminal
PHD domain of ING2 was targeted for ubiquitination (Fig. 3H).
However, unlike ING1b and ING2, the members ING3, 4, and 5
could not be degraded by Smurf1 (Fig. 4A). Notably, although the
PHD domain is highly conserved among the ING family, the central
region is not so conserved, and the central region of ING1b exhibits
50% homology to ING2, which is much higher than that of other
ING proteins with ING2 (Fig. 4C). We showed that ING2 interacts
with Smurf1 through this central region but not the highly con-
served PHD domain (Fig. 3G). So we suggested that the failure of
Smurf1 to mediate the degradation of ING3, 4 and 5 might be
caused by the low similarity of the central region, which leads to
the inability of ING3, 4, and 5 to interact with Smurf1. Indeed,
we revealed that Smurf1 interacted with ING2 and ING1b, but
not with ING3, 4 or 5, as revealed by co-immunoprecipitation as-
says (Fig. 4B). Consistent with our results, a previous report
showed that Smurf1 interacted with ING2 but not with ING3 and
ING4 [22]. Based on these data, we proposed that Smurf1 interacts
with the central region of ING2 and targeted the PHD domain of
ING2 for degradation. Therefore, both the E3 ligase and the degra-
dation targeting site of distinct ING family members are likely to be
different. In addition, mutations within PHD ﬁngers are found in
tumor tissue [5]. Whether these mutations affect the stability of
ING should be further explored in the future.
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